Identification of an Attenuated Substrain of Francisella tularensis SCHU S4 by Phenotypic and Genotypic Analyses

Julie A. Lovchik, Douglas S. Reed, Julie A. Hutt, Fangfang Xia, Rick Stevens, Thero Modise, Eileen M. Barry, Terry WuPathogens 2021 · DOI

TL;DR

This study identifies an attenuated substrain of Francisella tularensis SCHU S4, designated NR-643/FTS-635, which exhibits significantly reduced virulence in both rat and rabbit models of pneumonic tularemia compared to previously characterized SCHU S4 stocks. The findings highlight the critical need for well-characterized, genetically consistent strains in vaccine and therapeutic development for tularemia.

What Problem Does This Paper Address?

Francisella tularensis is a highly infectious bacterium that causes tularemia, a potentially fatal disease. The most virulent form, pneumonic tularemia, is particularly dangerous and is considered a potential bioweapon. Our understanding of its pathogenesis and the development of countermeasures largely relies on studies using the F. tularensis subsp. tularensis strain SCHU S4. However, SCHU S4 has been maintained and propagated in various laboratories for decades, raising concerns about potential genetic drift and altered virulence. This study addresses the critical question of whether different stocks of SCHU S4, maintained independently, have diverged in their virulence and if these differences are genetically based. This is crucial because using a less virulent or genetically altered strain in efficacy studies could lead to inaccurate assessments of vaccine and therapeutic effectiveness, potentially hindering the development of much-needed countermeasures.

Methods

The researchers employed a multi-pronged approach combining phenotypic and genotypic analyses.

  • Phenotypic Analysis (Virulence Studies):
    • Animal Models: Fischer 344 (F344) rats and New Zealand White (NZW) rabbits were used to model pneumonic tularemia.
  • Aerosol Challenge: Bacteria were administered via aerosol to mimic natural infection routes.
  • Virulence Assessment: Survival rates, weight loss, clinical signs, and bacterial burdens in organs were monitored over time. Different challenge doses were used to establish dose-response relationships and compare lethal doses (LD50).
  • Genotypic Analysis (Genome Sequencing):
    • Whole Genome Sequencing: DNA from the different SCHU S4 stocks was sequenced using high-throughput sequencing technologies.
  • Bioinformatics Analysis: * Read Mapping and Alignment: Sequencing reads were mapped to the published reference SCHU S4 genome to identify variations.
  • De Novo Assembly: Genomes were assembled independently to identify structural differences.
  • Variant Calling: Single nucleotide polymorphisms (SNPs), insertions, deletions, and larger structural variations (like inversions) were identified.
  • Comparison: Genetic differences were compared between the different SCHU S4 stocks and the reference genome.

Datasets

The study utilized several well-characterized strains of Francisella tularensis:

  • SCHU S4 Stocks:
    • NR-28534 (Master Cell Bank, BEI Resources)
    • NR-10492 (Submaster Cell Bank, BEI Resources, derived from NR-28534)
    • NR-643 (BEI Resources, previously used in a mouse study)
    • FTS-635 (Battelle Memorial Institute)
  • Comparator Strain:
    • MA00-2987 (BEI Resources, a virulent type A clinical isolate from Massachusetts)

The reference genome used for comparison was the published SCHU S4 genomic DNA sequence (GenBank accession number AJ749949.2).

Key Insights and Ideas

  • Not all SCHU S4 is created equal: The study definitively shows that different laboratory stocks of the SCHU S4 strain, despite sharing the same name, can exhibit significant differences in virulence. This is a crucial realization for researchers working with this pathogen.
  • Genetic drift is a real concern: The independent maintenance and passage of bacterial strains over time can lead to genetic alterations that impact their biological properties, such as virulence. This underscores the importance of rigorous strain characterization.
  • Virulence is a complex phenotype: The attenuated strains (NR-643/FTS-635) showed reduced bacterial replication and dissemination, suggesting that their genetic differences impact the bacteria's ability to establish and spread infection effectively within the host.
  • Implications for research standards: The findings strongly advocate for the clear designation of distinct substrains and the discontinuation of using attenuated strains like NR-643/FTS-635 in studies aiming to evaluate the efficacy of vaccines and therapeutics against virulent F. tularensis. This ensures that research findings are reproducible and relevant to combating the actual disease.

Key Results

  • Phenotypic Attenuation:
    • In F344 rats, NR-643 and FTS-635 were found to be highly attenuated compared to NR-28534, NR-10492, and MA00-2987. Rats exposed to NR-28534, NR-10492, and MA00-2987 died within 4-8 days, while all rats exposed to NR-643 or FTS-635 survived.
  • In NZW rabbits, NR-643 caused morbidity but no mortality, even at a dose 500 times the LD50 for NR-10492. Infected rabbits showed transient fever and moderate weight loss, with significantly reduced bacterial burdens in organs compared to NR-10492 infected rabbits.
  • Genotypic Differences:
    • NR-28534 and NR-10492 were genetically identical to each other and nearly identical to the reference SCHU S4 sequence, differing mainly by a large inversion.
  • NR-643 and FTS-635 were identical to each other and differed from the reference SCHU S4 sequence by nine regions of difference, including SNPs, a frameshift mutation, and an 11 bp deletion. These genetic differences are proposed to be responsible for their attenuated virulence.

Limitations and Future Work

  • Specific Genetic Determinants: While nine regions of difference were identified between the attenuated and reference strains, the study acknowledges that it is unclear which specific mutation(s) or combination thereof are responsible for the decreased virulence. Further studies are needed to dissect the exact genetic mechanisms.
  • Mixed Population: For NR-643 and FTS-635, the data suggested a mixed population at the 11 bp deletion site, indicating that these strains might not be entirely homogenous.
  • Future Work: The authors strongly recommend that NR-643/FTS-635 be clearly designated as a separate SCHU S4 substrain and not used in future efficacy studies. They also emphasize the need for reliable, well-characterized SCHU S4 challenge strains that are produced and passaged under defined conditions and periodically sequenced to maintain genetic and phenotypic homogeneity.

Summary updated

Abstract

Pneumonic tularemia is a highly debilitating and potentially fatal disease caused by inhalation of <i>Francisella tularensis.</i> Most of our current understanding of its pathogenesis is based on the highly virulent <i>F. tularensis</i> subsp. <i>tularensis</i> strain SCHU S4. However, multiple sources of SCHU S4 have been maintained and propagated independently over the years, potentially generating genetic variants with altered virulence. In this study, the virulence of four SCHU S4 stocks (NR-10492, NR-28534, NR-643 from BEI Resources and FTS-635 from Battelle Memorial Institute) along with another virulent subsp. <i>tularensis</i> strain, MA00-2987, were assessed in parallel. In the Fischer 344 rat model of pneumonic tularemia, NR-643 and FTS-635 were found to be highly attenuated compared to NR-10492, NR-28534, and MA00-2987. In the NZW rabbit model of pneumonic tularemia, NR-643 caused morbidity but not mortality even at a dose equivalent to 500x the LD<sub>50</sub> for NR-10492. Genetic analyses revealed that NR-10492 and NR-28534 were identical to each other, and nearly identical to the reference SCHU S4 sequence. NR-643 and FTS-635 were identical to each other but were found to have nine regions of difference in the genomic sequence when compared to the published reference SCHU S4 sequence. Given the genetic differences and decreased virulence, NR-643/FTS-635 should be clearly designated as a separate SCHU S4 substrain and no longer utilized in efficacy studies to evaluate potential vaccines and therapeutics against tularemia.
BibTeX
@inproceedings{lovchik2021identification,
  author = {Julie A. Lovchik and Douglas S. Reed and Julie A. Hutt and Fangfang Xia and Rick Stevens and Thero Modise and Eileen M. Barry and Terry Wu},
  title = {{Identification of an Attenuated Substrain of Francisella tularensis SCHU S4 by Phenotypic and Genotypic Analyses}},
  booktitle = {Pathogens},
  year = {2021},
  doi = {10.3390/pathogens10060638},
}
Figure